Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases.

Abstract

OBJECTIVE To determine whether anabolic hormones that affect the musculoskeletal system and active on the immune cells changed during cyclosporin A (CysA) therapy. METHODS We carried out a randomized study of patients with rheumatic disease attending the outpatient clinic for rheumatic diseases. Twenty-four patients with chronic arthritis [20 with… (More)

Topics

Cite this paper

@article{Ferraccioli1995CyclosporinAI, title={Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases.}, author={Gianfranco Ferraccioli and Paola Guerra and Vincenzo Rizzi and Ettore G. Bartoli}, journal={The Journal of rheumatology}, year={1995}, volume={22 6}, pages={1060-4} }